NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$15.67
+0.18 (+1.16%)
As of Feb 8, 1:50 PM ET ·
Income Statement
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Revenue 91.38M 75.56M 386.86M 354.79M 322.64M
Net Income -31,036,146 -23,098,099 29.56M 30.47M 23.82M
EPS
Profit Margin -34.0% -32.3% 7.6% 8.6% 7.4%
Rev Growth +20.9% +20.9% +14.5% -3.6% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Total Debt 230.00M 230.00M 128.25M 135.86M 137.71M
Total Equity 30.96M 30.96M 315.26M 359.61M 343.18M
D/E Ratio 7.43 7.43 0.41 0.38 0.40
Cash Flow
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
EBITDA -24,198,069 -19,009,481 39.70M 37.66M 35.61M
Free Cash Flow 26.29M 33.72M 30.25M